Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : Healthcare advancements

Gilead's Global Efforts Towards HCV Elimination by 2030: Progress and Collaboration

Gilead's Global Efforts Towards HCV Elimination by 2030: Progress and Collaboration
02/16/2024 | Citizenship
Carrie Frenette, a veteran liver specialist, reflects on her patients with hepatitis C (HCV) before 2013, the watershed year when the FDA approved Gilead's groundbreaking medicine, marking the advent of curative therapy for HCV. Recalling the limitations and harsh side effects of earlier...
Antiviral therapy, Disease eradication, Gilead initiatives, Global health, HCV elimination, Healthcare advancements, Hepatitis C treatment, Medical research, Public health collaboration, WHO Essential Medicine

Discover AMR Action Fund's Investments in Antimicrobial Solutions

Discover AMR Action Fund's Investments in Antimicrobial Solutions
10/09/2023 | Companies
Antibiotics have revolutionized healthcare and played a vital role in saving numerous lives. However, the growing problem of antimicrobial resistance (AMR) is reducing the effectiveness of existing antibiotics. Addressing AMR is a complex challenge with no easy solution, but we are fully committed...
AMR Action Fund, AMR Action Fund updates, AMR Action Fund website, AMR prevention, Antibiotic development, Antibiotic innovation, Antibiotic research, Antimicrobial investments, Antimicrobial resistance funding, Fighting drug-resistant infections, Future of antimicrobials, Global health initiatives, Healthcare advancements, Healthcare resources, Healthcare solutions, Infectious disease treatment, Medical innovations, Patient access to antibiotics, Pharmaceutical investments, Physician access to antimicrobials


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com